According to the National Institutes of Health, nearly 26 million people in the U.S. have diabetes (8.3% of the population). Over 200,000 persons less than 20 years old have either type 1 or 2 diabetes.
Working with the Center of Excellence in Diabetes & Endocrinology (CEDE) in Sacramento (Dr. Prakasam), researchers from UC Berkeley (Dr. Seto) and Aalborg University in Denmark (Dr. Hejlesen and Visiting PhD Student Jensen) are studying the efficacy of continuous glucose monitors (CGMs) among insulin pump users. In this randomized clinical trial, one group of diabetics will receive regular notifications when their CGMs detect low levels of interstitial fluid glucose versus a comparison group that will not. Study subjects will be closely monitored using the CalFit smartphone system, which will record their physical activity levels and their dietary intake of carbohydrates.
This study is supported by the Danish Agency for Science, Technology and Innovation (DASTI).